Advisory Board and Editors Cell Biology
Rohit Upadhyay
Dr. Rohit Upadhyay is a Research Scientist in the School of Medicine at Tulane University.
He has skills and expertise in the following areas; Cancer Genetics, Cell and Molecular biology, Kidney Injury, Pharmacology, and Molecular mechanisms of complex diseases.
Yegor S Vassetzky
Yegor Vassetzky graduated from the Moscow State University. After a PhD thesis in molecular biology at the Engelhardt Institute of Molecular Biology in Moscow, he worked as a postdoctoral fellow in laboratories of Klaus Scherrer (Paris), Susan Gasser (Lausanne) and Marcel Méchali (Montpellier). Since 2002 he heads the laboratory of Nuclear Organization and Pathologies at Gustave Roussy Institute (Villejuif, France). His main research interests concern epigenetic regulation in cancer and neuromuscular diseases. Yegor Vassetzky is Associate Editor for Biopolymers & Cell, and member of the Editorial Board of PeerJ and Oncotarget.
Natascia Ventura
Natascia Ventura received her MD and PhD degrees at the University of Rome and her post-doctoral training at the University of Colorado at Boulder. Since 2012 she leads the Mitochondrial-associated aging and diseases group and her research mainly uses C. elegans as a powerful genetic tractable organism to unravel mechanistic aspects of mitochondrial-stress control of longevity and to develop models for human mitochondrial-associated diseases.
Shibiao Wan
Dr. Shibiao Wan is currently an Assistant Professor in the Department of Genetics, Cell Biology and Anatomy, and the Co-Director for the Bioinformatics and Systems Biology (BISB) PhD Program at University of Nebraska Medical Center (UNMC). He is also an Assistant Professor (courtesy) in the Department of Biostatistics at UNMC.
With more than 15 years of experience in machine learning, bioinformatics, and computational biology, Dr. Wan has published >60 articles in top-tiered journals such as Genome Research, Nature Communications, Science Advances, Circulation Research, Briefings in Bioinformatics, and Bioinformatics. Dr. Wan is the Editor-in-Chief for Current Proteomics, and an Associate Editor/Academic Editor/Editorial Board Member for a series of prestigious journals such as Briefings in Functional Genomics, Heliyon, BMC Bioinformatics, International Journal of Microbiology, PeerJ Computer Science, BioMed Research International, and Computational and Mathematical Methods, and a guest associate editor for multiple high-impact journals.
He is a Scientific Program Committee (SPC) member for American Medical Informatics Association (AMIA) Annual Symposium and a Technical Program Committee (TPC) member for >20 machine learning related international conferences including IEEE ICTAI. Dr. Wan is also a reviewer for >70 prestigious journals including Nature Biotechnology, Nature Methods, Nature Communications, Nature Computational Science, Science Advances, Nucleic Acids Research, Advanced Science, Cancer Research, Genome Biology, and Genome Medicine. Dr. Wan has received a number of accolades including the Springer Nature Editor of Distinction Award in 2025 by Springer Nature, the New Investigator Award in 2024 by UNMC, the FIRST Award in 2023 by Nebraska EPSCoR, the Outstanding Young Alumni Award in 2022 by HK PolyU as well as the Global Peer Review Awards (top 1%) in “Cross-Field” and “Biology and Biochemistry” in 2019 by Clarivate. Dr. Wan is a member of AACR, AMIA, ISCB and ACM and an IEEE Senior Member.
Christine J Watson
Professor of Cell and Cancer Biology in the Department of Pathology, University of Cambridge. Graduate of the University of Glasgow and Imperial College, London.
Claire M Wells
Dr. Wells completed her PhD in 1998 from Kings College London and completed postdoctoral studies in the laboratory of Prof. Anne Ridley at University College London before returning to King's in 2003. Dr. Wells is now a Senior lecturer in the Division of Cancer Studies. She has published more than 20 papers in reputed journals serves as an editorial board member for a number of international journals and is currently associated with Cancer Research Technology’s PAK drug discovery programme.
Joëlle Wiels
Joëlle Wiels received her PhD in Genetics from Université Paris 6-Denis Diderot and then spent two years as a Post-doctoral fellow in the Division of Biochemical Oncology (Fred Hutchinson Cancer Research Center) headed by Professor Hakomori. She then moved back to France where she studied the role of glycosphingolipids in both normal and tumoral B lymphocytes. Since 1991, her main research interests include analysis of apoptotic signaling pathways and of resistance to cell death developped by B cell lymphomas. She is currently affiliated at the METSY CNRS Unit located at the Gustave Roussy Institut in Villejuif (France)
Diego Veras Wilke
Professor of physiology and pharmacology at Federal University of Ceara. Research focuses on a combination of marine natural product discovery with molecular and cellular biology to identify new anticancer leads.
Zhijin Wu
I develop statistical methodology and software for the analysis of -omics data. I am particularly interested in the regulation of transcription: the molecular mechanism as well as its association with disease.
Joseph C Wu
Joseph C. Wu, MD, PhD is Director of the Stanford Cardiovascular Institute and Simon H. Stertzer Professor of Medicine (Cardiology) and Radiology at the Stanford School of Medicine. Dr. Wu received his MD from Yale University School of Medicine. He trained in internal medicine and cardiology at UCLA followed by a PhD in the Dept of Molecular Pharmacology. His clinical interests involve cardiovascular imaging and adult congenital heart disease. His lab works on biological mechanisms of patient-specific and disease-specific induced pluripotent stem cells (iPSCs). The main goals are to (i) understand basic cardiovascular disease mechanisms, (ii) accelerate drug discovery and screening, (iii) develop “clinical trial in a dish” concept, and (iv) implement precision cardiovascular medicine for prevention and treatment of patients. His lab uses a combination of genomics, stem cells, cellular & molecular biology, physiological testing, and molecular imaging technologies to better understand molecular and pathophysiological processes.
Hao Wu
Hao Wu is a patent scientist in an oncology-focused biotechnology company, Exelixis, Inc. She obtained her Ph.D. in molecular biology from Rowan University (previously known as the University of Medicine and Dentistry of New Jersey (UMDNJ) – Stratford Campus). With hands-on knowledge in various aspects of biology, including molecular biology, cell biology, biochemistry, immunology, neuroscience, oncology, Hao has worked on inventions spanning a broad range of technologies, for example, biologics, antibodies, biomarkers, diagnostics, cell therapy, gene therapy, and sequencing.
Lai-Hua Xie
Associate Professor at Rutgers-New Jersey Medical School, Editor of American Journal of Medical and Biological Research, Dataset Papers in Biology, Frontiers in Physiology, Journal of Cardiovascular Disease Research, PLOS One, World Journal Of Hypertension, and World Journal of Cardiology.